Core Insights - Medtronic has appointed Kate Benedict as the Senior Vice President and President of the Acute Care & Monitoring (ACM) division, which is part of its Medical Surgical Portfolio, effective June 10, 2025. Her extensive experience in the medical industry is expected to drive innovation and growth in this newly formed division [6][15]. Company Developments - Medtronic has undergone significant personnel changes in recent years, including the departure of key executives and the restructuring of its business units. The company announced in February 2024 that it would exit the unprofitable ventilator product line and merge its remaining patient monitoring and respiratory intervention businesses into the new ACM division [7][8]. - The ACM division is positioned to capitalize on a $100 billion market potential, focusing on hospital and home monitoring, particularly in chronic disease management and post-operative care [11][15]. Market Context - The demand for ventilators has sharply declined following the stabilization of the COVID-19 pandemic, leading to decreased profitability in this product line. Medtronic's strategic shift aims to focus on high-growth monitoring technologies [11][8]. - The ACM division's product offerings include pulse oximeters, remote patient monitoring, airway management, and respiratory monitoring products, which are essential for acute care, post-operative recovery, and chronic disease management [13][17]. Future Outlook - The appointment of Kate Benedict comes at a crucial time as the ACM division seeks new growth opportunities. Her cross-industry experience is anticipated to enhance the market expansion of products like HealthCast™ and Argos™ [11][15]. - Medtronic's revenue for the fiscal year 2024 was reported at $32.4 billion, with the Medical Surgical Portfolio, including ACM, accounting for approximately 26% of this total [11].